Exendin 3 (9-39) amide
DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-amide
Description
Application Data
Description
-
Truncated exendin-3 is a potent and selective glucagon-like peptide-1 receptor (GLP-1R) antagonist. This is a 30-peptide sequence from the N terminal region.
Application Data
-
Catalogue number crb1000986 Molecular Weight 3367.7 Sequence (one letter code) DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-amide
Sequence (three letter code) H-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Purity >95% cas 133514-43-9 Storage -20°C References Gasbjerg et al., (2021). Exendin (9‐39) NH2: Recommendations for clinical use based on a systematic literature review. Diabetes Obes Metab, 23(11): 2419. doi: 10.1111/dom.14507.
Gault et al., (2003). Effects of the novel (Pro3) GIP antagonist and exendin (9–39) amide on GIP-and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin. Diabetologia, 46(2): 222. doi: 10.1007/s00125-002-1028-x.
Manufactured in: United Kingdom Originally identified in Heloderma horridum horridum (Mexican beaded lizard), exendin-3 shares homology with vasoactive intestinal peptide (VIP), secretin, helospectin I and II and helodermin. Exendin-3 increases cellular cAMP levels and amylase release from pig pancreatic cells.
Truncated exendin-3 is a potent and selective GLP-1 receptor antagonist. It inhibits cAMP production and insulin release induced by GLP-1, exendin-3, and exendin-4. It also blocks the inhibitory effect of GLP-1 on food intake in rats. Exendin 3 (9-39) amide is being considered for clinical use in obese patients. This is based on the extensive and consistent data demonstrating its effectiveness as a tool to improve fasting and postprandial levels of glucose and glucagon.
You may also like…
-
Oxyntomodulin Heavy
HSQGTFTSDYSKY-[U-13C6,15N-Leu]-DSRRAQD-[U-13C9,15N-Phe]-VQW-[U-13C6,15N-Leu]-MNTKRNRNNIA-acid
View products -
GLP-1 (9-36) amide
EGTFTSDVSSYLEGQAAKEFIAWLVKGR-amide
View products -
Exendin-4 [Lys(AF647)]
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-[K(AF647 DBCO)]-amide
View products -
[Cys(Cyanine3)]-Exendin 4
[Cys(Cyanine3)]-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-amide
View products -
Glucagon like-peptide-2 (GLP-2)
DGSFSDEMNTILDNLAARDFINWLIQTKITD-acid
View products -
[5-FAM]-GLP-1 (7-36)
[5-FAM]-HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-amide
View products -
GLP-1 (7-36) [Cys(Sulfocyanine5)]
HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-[Cys(Sulfocyanine5)]-amide
View products -
Exendin 4
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH₂
View products -
Liraglutide
HAEGTFTSDVSSYLEGQAA-[Lys([Palm]-[g-Glu]-)]-EFIAWLVRGRG-acid
View products -
[5-FAM]-GLP-1
[5-FAM]-HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-amide
View products -
[Cys]-Exendin 4
[C]-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-amide
View products -
Exendin 4 (4–39)
GTFTSDLSKQMEEEAVRLFIE-W-LKNGGPSSGAPPPS-amide
View products -
GLP-1 (1-37)
HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG-acid
View products -
Teduglutide (GLP2 2G)
HGDGSFSDEMNTILDNLAARDFINWLIQTKITD-acid
View products -
Exendin 3
HSDGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH₂
View products -
Exendin 3 (9-39) amide
DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-amide
View products -
GLP (7-36) Heavy
HAEGT-[U-13C9,15N-Phe]-TSD-V-SSY-[U-13C6,15N-LEU]-EGQAAKEFIA-W-[U-13C6,15N-LEU]-VKGR-amide
View products -
Biotin-GLP-1 (7-36)
[Biotin]-HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-amide
View products -
[Biotin]-GLP-1
[Biotin]-HDEFERHAEGTFTSDVSSYLEGQAAKEFIA-W-LVKGR-amide
View products -
[Glp6,Pro9] Substance P (6-11)/Septide
[Pyr]-FFPLM-amide
View products